2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Olderdiffuse large B-cell lymphomaActive, not recruitingPhase 22026-06-04NCT04974216
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)Hematopathology Eligible or CAR-t Cell TreatmentRecruitingNot stated2026-03-04NCT04328298